Progression
Navigation Links
Progression at Biology News
Preliminary results from a large, randomized clinical trial for patients with previously untreated recurrent or metastatic breast cancer ?cancer that has spread from the breast to other parts of the body ?show that those patients who received bevacizumab (Avastin? in combination with standard chemotherapy had a longer time period before their cancer progressed than patients who received the same...
Disease progression model of pancreatic cancer developed by Penn researchers
Building on previous work, researchers at the University of Pennsylvania School of Medicine have developed an animal model of pancreatic cancer that closely mimics disease progression in humans. From this, they hope to develop new treatments for this deadly disease. Advanced pancreatic cancer is among the most lethal of cancers, with a one-year survival rate after chemotherapy of only 17 to 28 pe...Cell therapy slows progression of an inherited neurological disease; Improves motor skills in mice
In an important discovery, scientists have demonstrated that the progression of a type of genetic brain disease is slowed and symptoms are improved in mice that received cell transplants. , may have implications for developing new therapies for metachromatic leukodystrophy, or MLD, a fatal, relatively rare...Genome changes tracked during multiple myeloma initiation, progression and treatment
Scientists have made significant progress toward elucidating key genetic events associated with the development and progression of multiple myeloma (MM), an incurable malignancy that is the second most common cancer of the blood. The results, published in the April issue of Cancer Cell, provide new genetic and biological insights that open innovative directions for the discovery of effective ther...Insulin receptor stops progression of Alzheimer's disease
Stimulation of a receptor in the brain that controls insulin responses has been shown to halt or diminish the neurodegeneration of Alzheimer's disease, providing evidence that the disease can be treated in its early stages, according to a study by researchers at Rhode Island Hospital and Brown Medical School. Researchers have found that peroxisome-proliferator activated receptor (PPAR) ag...Progression at Biology Products
No data found
Search Progression biology products at Google
Search Progression biology products at Yahoo
Search Progression biology products at Msn
Progression at Biology Technology
Discovery may halt progression of Alzheimer's
Source: School of Pharmacy @ UW - Madison , an associate professor at the <...Progression at Medicine News
A way to slow the progression of Type 1 Diabetes
According to new research, a new drug that suppresses the immune system may slow the progression of type 1 diabetes. An early-phase clinical trial of 10 people aged 8 to 35 years with type 1 diabetes were treated with anti-CD3 mAb, a modified antibody.// A 14-day course of the drug appeared to slow the progressive decline in insulin production commonly seen in type 1 diabetics. Patient...Progression of Glaucoma could be controlled with early detection
Glaucoma, according to doctors, is a disease of the eye, which has no early warning signs and many affected patients are unaware they have the disease until it has advanced. And once someone has lost his or her vision from glaucoma, it cannot be regained. Researchers in New York and Sweden, focusing on a previous study called The Early Manifest Glaucoma Trial, conducted a study which looked// at...Shyness Linked To HIV Progression
Differences in neural activity may be putting shy people at increased risk for HIV and other infectious diseases say researchers according to a new study conducted.// Shyness has been linked to infectious disease for centuries. As early as the second century AD, doctors noted people with a "melancholic temperament" were more likely to develop illnesses. Research in modern times has suppo...Delaying The Progression Of Alzheimer’s Disease
Researchers say for the first time, a drug seems to slightly delay the progress from memory impairment to Alzheimer’s disease.// Previous studies have shown that without treatment, about 10 percent to 15 percent of patients with mild cognitive impairment will progress to Alzheimer’s disease each year. However, not every patient with the condition will progress to Alzheimer’s. R...Stopping The Progression Of Parkinson's Disease
About 1 percent of people over age 60 are affected by Parkinson’s disease. The condition is characterized by slowed motion, muscle rigidity, and tremors. Patients also suffer from loss of facial rigidity // and a shuffling walk. A drug already being used to treat the symptoms of Parkinson’s disease may also be able to stop its progression say researchers . The drug, pramipexole (Mirapex...Progression at Medicine Products
Allergens, Pediatric Allergy "March" (Progression) Profile
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...Company:ARUP Laboratories
Humphrey GPA Glaucoma Progression Analysys Software
Description:Only Humphrey GPA software accurately differentiates clinically significant progression of visual field loss from random variability, providing an advanced, proven method to enhance management of glaucoma for your patients. The software applies knowledge acquired from a multi-center clinical trial, in which the actual test/retest variability of hundreds of glaucoma patients was measured. By...Company:Carl Zeiss Meditec, Inc.
Progression at Medicine Technology
Treating Heart Disease Risk Factors May Slow Alzheimer's Disease Progression
- Late Life Weight Loss and "Motivational Reserve" May Also AffectAlzheimer's Risk - WASHINGTON, June 10, 2007 /PRNewswire-USNewswire/ -- A new studysuggests that treating risk factors for heart disease and stroke,such as high blood pressure and diabetes, may slow the progressionof Alzheimer's disease, according to research reported today at the2nd Alzheimer's Association International Co...CHICAGO - June 3, 2007 - Schering-Plough Corp. announced resultsfrom a Phase III study that showed maintenance chemotherapy withCaelyx (pegylated liposomal doxorubicin hydrochloride)significantly prolonged time to progression (TTP) in patients withmetastatic breast cancer with infrequent and manageable clinicaltoxicity after first-line chemotherapy. These data were presentedtoday at the...
Abstracts: 2000, 2002 CHICAGO/DARMSTADT, Germany, June 4, 2007 – Results of aPhase I/IIa study presented today at the American Society ofClinical Oncology (ASCO) annual meeting in Chicago demonstrate theclinical activity of cilengitide in patients with newly diagnosedglioblastoma – a particularly aggressive form of brain tumor.Cilengitide i...
Presentation at ASCO Plenary Session Reports EORTC 40983 (EPOC)Intergroup Study Results CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Results of therandomized phase III EORTC 40983 Intergroup study, or EPOC study,demonstrate for the first time that peri-operative (pre and postsurgery) FOLFOX4 (Eloxatin(R) (oxaliplatin injection) incombination with a standard chemotherapy regimen for co...
PLANTATION, Fla., May 08, 2007 /PRNewswire-FirstCall/ --Viragen, Inc. and Viragen International, Inc. today announcedresults from a sponsored in vitro study conducted at UmeaUniversity in Sweden, which found that Multiferon(R) (multi-subtype, human alpha interferon) suppressed development ofresistant human melanoma clones to a far greater degree thanrecombinant alpha interferon. The stud...
Other TagsClearviewImmunoCardOther Contentssepticsepticsepticsepticseptumserologyserologyironironironironironironironironcalciumcalciumcalciumcalciumcalciumcalciumcalciumcalciumcalciumphosphorusphosphorusphosphorusphosphorusphosphorusphosphoruseducationeducationeducationeducationeducationeducationeducationeducation
MaybeMomDonnaGastroccultCLOtestProntoHpfastSERIMClearviewTRINITYFlexSureImmunoCardBioSignQuickVue+ACCUTEST
(Date:5/16/2008)...ffices of Howard G. Smith,announces a June 9, 2008...ecurities class action lawsuit filed on behalf of ...e common stock of Inverness Medical,Innovations, I... IMA ) in the,Company,s secondary public offering .... The shareholder lawsuit is pending in the United...
(Date:5/16/2008)...s want agency to act, not wait years , ,...umer drug ads on television should include a toll-...port adverse side effects, U.S. health experts sug...hat advises the U.S. Food and Drug Administration....A for print ads. At Friday,s meeting, the panel di...
(Date:5/16/2008)...HINGTON, May 16 /PRNewswire-USNewswire/ -- More th...s in the Greater Portland, Oregon and,Vancouver, W...ract as,Teamsters., "The Teamsters are pleased th...act that gives them job protection and a secure re... Jim Hoffa., The workers, both full-time and part...
(Date:5/16/2008)...fit from calcitriol, an oral form , , FR...vitamin D may cut the risk of death for people wit...ut one quarter, a new study suggests. , During...se being treated with calcitriol, an oral form of ...th lowered by 26 percent when compared with those ...
Breaking Medicine News(10 mins):Health News:Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc. 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 3Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2[0] Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc.[0] FDA Panel Considers Toll-Free Number for TV Drug Ads[0] Paramedics, EMTs in Oregon, Washington State Ratify First-Ever Teamsters Contract[0] Vitamin D Use Linked to Lower Mortality in Kidney Patients
(Date:5/15/2008)...ge has long been a concern for environmental scien... problem of excessive reactive nitrogen in the env...f environmental scientists who study how the eleme...lters local and global ecosystems and potentially ...environmental scientists bring the problem to the ...
(Date:5/15/2008)... has developed a simple artificial cell with which...wo of the most basic cell components: the cell mem... surrounds the structures in living cells. The wo...ke advantage of properties of cell organization to...findings will be published later this month (late ...
(Date:5/15/2008)...ether bacteria stick to surfaces depends partly on...created ultrathin films made of polymers that coul... to control microbe accumulation. , The inexpens...e layer of protection for the health care industry...red infections, which take the lives of 100,000 pe...
(Date:5/15/2008)...itrogen compounds emitted into the atmosphere by h...use of nitrogen fertilizers enters the oceans and ...m the atmosphere, concluded a team of internationa...shed Professor of Oceanography and Atmospheric Sci... institutions around the world presented its concl...
Breaking Biology News(10 mins):Addressing the 'nitrogen cascade' 2Addressing the 'nitrogen cascade' 3Simple model cell is key to understanding cell complexity 2MIT crafts bacteria-resistant films 2MIT crafts bacteria-resistant films 3Atmosphere threatened by pollutants entering ocean, prof says 2Atmosphere threatened by pollutants entering ocean, prof says 3Premier Research Appoints Global Head of Human Resources 642 1Premier Research Appoints Global Head of Human Resources 642 2Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease 297 1Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease 297 2Once a Year Bone Drug Lowers Fracture Risk 1455 1Once a Year Bone Drug Lowers Fracture Risk 1455 2Once a Year Bone Drug Lowers Fracture Risk 1455 3DRAXIS to Present at the 2007 UBS Global Life Sciences Conference 1451 1DRAXIS to Present at the 2007 UBS Global Life Sciences Conference 1451 2DRAXIS to Present at the 2007 UBS Global Life Sciences Conference 1451 3DRAXIS to Present at the 2007 UBS Global Life Sciences Conference 1451 4| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |